| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.085 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |